TGFB1 and neoplasm: Targeting TGF-β is potentially problematic for several reasons; in the early stages of tumorigenesis it acts as a tumour suppressor; it also plays an important role in tissue homeostasis, and early testing of small molecule TGF-β1 inhibitors highlighted on-target cardiac toxicities and development of cutaneous carcinomas [105].